Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Timothy Graubert

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Blood|April 25, 2008
AML1 and Evi1: coconspirators in MDS/AML?Timothy Graubert
Seminars in Hematology|October 15, 2014
AML genomics for the clinicianTimothy Graubert, Richard Stone
Hematology. American Society of Hematology. Education Program|December 14, 2011
Genetics of myelodysplastic syndromes: new insightsTimothy Graubert, Matthew J Walter
Developmental Biology|May 20, 2005
Sca-1 negatively regulates proliferation and differentiation of muscle cellsPatrick O Mitchell, Todd Mills, Roddy S O'Connor, et al.
British Journal of Haematology|September 27, 2003
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicityRizwana Chohan, Ravi Vij, Douglas Adkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantationThomas Fong, Kathryn Trinkaus, Douglas Adkins, et al.
Nature Biotechnology|March 24, 2015
Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cellsAndriana G Kotini, Chan-Jung Chang, Ibrahim Boussaad, et al.
The Oncologist|July 19, 2022
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare NetworkDora Dias-Santagata, Rebecca S Heist, Adam Z Bard, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Blood|April 25, 2008
AML1 and Evi1: coconspirators in MDS/AML?Timothy Graubert
Seminars in Hematology|October 15, 2014
AML genomics for the clinicianTimothy Graubert, Richard Stone
Hematology. American Society of Hematology. Education Program|December 14, 2011
Genetics of myelodysplastic syndromes: new insightsTimothy Graubert, Matthew J Walter
Developmental Biology|May 20, 2005
Sca-1 negatively regulates proliferation and differentiation of muscle cellsPatrick O Mitchell, Todd Mills, Roddy S O'Connor, et al.
British Journal of Haematology|September 27, 2003
Long-term outcomes of allogeneic stem cell transplant recipients after calcineurin inhibitor-induced neurotoxicityRizwana Chohan, Ravi Vij, Douglas Adkins, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 25, 2007
A randomized double-blind trial of hydroxychloroquine for the prevention of chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantationThomas Fong, Kathryn Trinkaus, Douglas Adkins, et al.
Nature Biotechnology|March 24, 2015
Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cellsAndriana G Kotini, Chan-Jung Chang, Ibrahim Boussaad, et al.
The Oncologist|July 19, 2022
Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare NetworkDora Dias-Santagata, Rebecca S Heist, Adam Z Bard, et al.
Pageof 1